Market revenue in 2023 | USD 949.6 million |
Market revenue in 2030 | USD 1,605.6 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 73.68% in 2023. Horizon Databook has segmented the Canada high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Canada is anticipated to hold significant market share during the forecast period owing to rising prevalence of chronic diseases coupled with increasing research on oncology & clinical pharmacology research. According to Canadian Cancer Society, almost 1 in 2 people in Canada is expected to be diagnosed with cancer at some point in their lifetime.
According to Canadian Institute for Health Information, healthcare expenditure in the nation is expected to reach USD 264 billion, representing 11.6% of the nation’s GDP in 2020. The country spends over 15.7% of this expenditure on drugs.
These factors indicate the rising demand for personalized medicine, which is in turn boosting the demand for biopharmaceuticals, thereby propelling the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Canada high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account